From Office of TX Attorney General <[email protected]>
Subject Paxton Supports Efforts to Stop FDA from Expanding Access to Abortion-Inducing Drugs
Date March 7, 2023 2:54 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Seal________________________________________________________________________




*FOR IMMEDIATE RELEASE*

March 7, 2023

www.texasattorneygeneral.gov




*PRESS OFFICE: (512) 463-2050*

[email protected]





?

*Paxton Supports Efforts to Stop FDA from Expanding Access to Abortion-Inducing Drugs?*

?

AUSTIN ??Attorney General Paxton has joined a Mississippi-led amicus brief in a case challenging reckless and illegal actions by the U.S. Food and Drug Administration (?FDA?) that expand access to abortion-inducing drugs being sent through the mail.??

?

Following President Biden?s directive, issued in the wake of the Supreme Court?s "Dobbs "decision, the FDA has opted to promote an extreme abortion agenda by ignoring federal law, which bars abortion drugs such as mifepristone from being sent through the mail. Compounding this violation of federal law is the fact that FDA?s approval of mifepristone contradicts the agency?s own regulations.???

?

In this instance, FDA is not acting to advance public health, protect women and the unborn, or stay in compliance with the law. Rather, it is attempting to fall in lockstep with the Biden Administration?s political agenda at the expense of the public interest.??

?

The amicus states: ?In 2016, the FDA rolled back many safety requirements?allowing mifepristone to be prescribed later in pregnancy, by non-doctors, and with only one in-person visit. In 2021, the agency halted the remaining in-person dispensing requirements during the COVID-19 pandemic and later abandoned the requirements altogether. After decades of such efforts, the FDA now broadly condones a wide-ranging mail-order abortion-drug regime. Plaintiffs here have moved to preliminarily enjoin and set aside the FDA?s actions.??

?

Paxton also recently sent [ [link removed] ] a letter to the FDA criticizing the rule change.??

?

To read the full amicus brief, click here [ [link removed](N.D.%20Tex.)--%20Amicus%20Brief.pdf?utm_content=&utm_medium=email&utm_name=&utm_source=govdelivery&utm_term= ].??

? ?

###







Stay Connected with Office of Texas Attorney General on
Facebook [ [link removed] ]?-?Twitter [ [link removed] ]?-?Instagram [ [link removed] ]?-?Email [ [link removed] ]

?Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ [link removed] ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com [ [link removed] ].


________________________________________________________________________

This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: Office of Texas Attorney General ?300 W. 15th Street?? Austin, TX?78701 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis